Jam Miller shared a fresh NIL update on Friday as Alabama heads into the final stretch of its season. Jam Miller and the ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

The mutated strain, known as subclade K, is causing a surge in cases in the United Kingdom, Canada, and Japan. Here's what to ...

When it comes to the upcoming influenza season, there's a potential mismatch between the vaccine and what might circulate, raising the risk that the flu season could be severe. And that risk could be ...

The U.S. may be entering another rough winter for flu, according to early data. “The signs are, it could be a big season,” says Richard Webby, who studies the flu at St. Jude Children’s Research ...

Lots more details about the fallout from STAT’s John Wilkerson. Read more here.

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The United States may be headed for a rough flu season, with a virus that causes more severe symptoms than the one last year ...

Massachusetts could be headed for a sharp uptick in flu cases in the coming weeks, public health experts warn, as a newly ...

We're almost in the peak of flu season, with the CDC's recent report saying activity is "low but rising." Here's what ...

Peak respiratory virus season is quickly approaching in Illinois, and public health officials recommend three vaccines, ...